Literature DB >> 10482906

Pregnancy reduces brain sigma receptor function.

R Bergeron1, C de Montigny, G Debonnel.   

Abstract

1. Sigma (sigma) receptors have recently been cloned, though their endogenous ligand(s) remain unidentified. However, some neuroactive steroids, such as progesterone, have a high affinity for these receptors. Some sigma ligands, such as DTG, (+)-pentazocine and DHEA, act as sigma 'agonists' by potentiating the neuronal response to NMDA. Others, such as haloperidol, NE-100 and progesterone, act as sigma 'antagonists' by reversing the potentiations induced by sigma 'agonists'. 2. We compared the effects of sigma 'agonists' in four series of female rats: in controls, at day 18 of pregnancy, at day 5 post-partum, and in ovariectomized rats following a 3-week treatment with a high dose of progesterone. 3. In pregnant rats and following a 3-week treatment with progesterone, 10 fold higher doses of DTG, (+)-pentazocine and DHEA were required to elicit a selective potentiation of the NMDA response comparable to that obtained in control females. Conversely, at day 5 post-partum and following the 3-week treatment with a progesterone and after a 5-day washout, the potentiation of the NMDA response induced by the sigma 'agonist' DTG was greater than in control females. 4. The present data suggest that endogenous progesterone acts as an 'antagonist' at sigma receptors. The resulting changes in the function of sigma receptors during pregnancy and post-partum may be implicated in emotional phenomena occurring during these periods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482906      PMCID: PMC1566170          DOI: 10.1038/sj.bjp.0702724

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.

Authors:  B Gronier; G Debonnel
Journal:  Eur J Pharmacol       Date:  1999-03-05       Impact factor: 4.432

3.  N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors.

Authors:  F P Monnet; G Debonnel; J L Junien; C De Montigny
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

4.  Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to sigma 1 receptors in the mouse forebrain.

Authors:  T Maurice; F J Roman; A Privat
Journal:  J Neurosci Res       Date:  1996-12-15       Impact factor: 4.164

Review 5.  Neuroactive steroids.

Authors:  S M Paul; R H Purdy
Journal:  FASEB J       Date:  1992-03       Impact factor: 5.191

6.  Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.

Authors:  R Bergeron; C de Montigny; G Debonnel
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

7.  Tris inhibits (+)-[3H]SKF-10,047 binding to sigma receptors.

Authors:  D J McCann; T P Su
Journal:  Neurosci Lett       Date:  1992-07-20       Impact factor: 3.046

8.  Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate.

Authors:  R Bergeron; C de Montigny; G Debonnel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

9.  Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems.

Authors:  T P Su; E D London; J H Jaffe
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

10.  NE-100, a novel sigma receptor ligand: in vivo tests.

Authors:  S Okuyama; Y Imagawa; S Ogawa; H Araki; A Ajima; M Tanaka; M Muramatsu; A Nakazato; K Yamaguchi; M Yoshida
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

View more
  7 in total

1.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

2.  Evidence for sigma-1-like receptors in isolated rat liver mitochondrial membranes.

Authors:  Anis Klouz; Rosa Sapena; Jun Liu; Tangui Maurice; Jean-Paul Tillement; Vassilios Papadopoulos; Didier Morin
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

3.  Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists.

Authors:  Jonathan L Katz; Takato Hiranita; Theresa A Kopajtic; Kenner C Rice; Christophe Mesangeau; Sanju Narayanan; Ahmed H Abdelazeem; Christopher R McCurdy
Journal:  J Pharmacol Exp Ther       Date:  2016-04-21       Impact factor: 4.030

Review 4.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

Review 5.  Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels.

Authors:  Sara L Morales-Lázaro; Ricardo González-Ramírez; Tamara Rosenbaum
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

6.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

7.  Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group.

Authors:  Bahram Aminmansour; Hossein Nikbakht; Abbas Ghorbani; Majid Rezvani; Paiman Rahmani; Mostaffa Torkashvand; Mohammadamin Nourian; Mehran Moradi
Journal:  Adv Biomed Res       Date:  2012-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.